• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    More On SPARC.NS



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Sun Pharma Advanced Research Company Limited (SPARC.NS)

    351.40 Down 5.05(1.42%) Nov 27, 4:59AM EST
    ProfileGet Profile for:
    Sun Pharma Advanced Research Company Limited
    Sun Pharma Advanced Research Centre
    Akota Road
    Vadodara, 390020
    India - Map
    Phone: 91 26 5233 0815
    Website: http://www.sunpharma.in

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:331

    Business Summary 

    Sun Pharma Advanced Research Company Limited, a pharmaceutical company, engages in research and development of drugs and delivery systems in India and internationally. The company develops products in the areas of oncology, dermatology, ophthalmology, CNS, respiratory, and pain management. It offers Levetiracetam ER for epilepsy. The company is also developing Latanoprost BAK free eye drops for glaucoma; Paclitaxel injection concentrates for nanodispersion for cancer; Baclofen gastric retention systems for spasticity; Fluticasone + Salmeterol DPI for asthma/COPD; SUN-K706 for chronic myelogenous leukemia; and Brimonidine OD for glaucoma. The company also develops Tizanidine ER and Abuse Deterrent formulations for pain; SUN-597 Topical for atopic dermatitis; Minocycline Topical for acne; Octreotide LAR for acromegaly; and Docetaxel injection concentrate for nanodispersion. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sun Pharma Advanced Research Company Limited

    Key Executives 
    Mr. Dilip Shantilal Shanghvi , 59
    Chairman, Managing Director and Member of Corp. Social Responsibility Committee
    Mr. Sudhir Vrundavandas Valia , 59
    Chief Financial Officer, Whole-Time Director, Chairman of Corp. Social Responsibility Committee, Member of Exec. Committee and Member of Stakeholders' Relationship Committee
    Mr. Anil Raghavan ,
    Chief Exec. Officer
    Mr. Debashis Day ,
    Compliance Officer and Company Sec.
    Dr. Subhas Bhowmick , 59
    VP of R&D (Formulation)
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.